|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash and cash equivalents | ||||||
| Restricted cash | ||||||
| Accounts receivable, net | ||||||
| Related party receivables | ||||||
| Other receivable | ||||||
| Related Party | ||||||
| Nonrelated Party | ||||||
| Total other receivable | ||||||
| Derivative asset | ||||||
| Inventory | ||||||
| Other current assets | ||||||
| Total current assets | ||||||
| Security deposit | ||||||
| Property, plant and equipment | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current liabilities | ||||||
| Accounts payable | ||||||
| Accounts payable to Parent | ||||||
| Non-Redemption Agreement | ||||||
| Professional fees payable | ||||||
| Related party payable | ||||||
| Loans payable to related party | ||||||
| Related Party | ||||||
| Total loans payable to related party | ||||||
| Notes payable, current portion | ||||||
| Warrant liabilities | ||||||
| Accrued expenses and other current liabilities | ||||||
| Total current liabilities | ||||||
| Financial liability, net of closing costs | ||||||
| Notes payable, net of current maturities | ||||||
| TOTAL LIABILITIES | ||||||
| STOCKHOLDERS’ EQUITY | ||||||
| Common Stock; $0.0001 par value, 500,000,000 shares authorized; 394,530,494 and 206,473,533 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||
| Stock subscription receivable, from related party | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
